Journal article
Abstract A109: Targeting pyrimidine biosynthesis as a metabolic vulnerability in brain metastasis
Abstract
Abstract Metastasis, the spread of cancer cells from one part of the body to another, is the leading cause of death among cancer patients. Lung-to-Brain metastasis remains a largely understudied disease that possesses a dismal prognosis due to the lack of effective therapies. We previously identified purine metabolism as a metabolic vulnerability of brain metastases.  Here, we sought to identify whether pyrimidine biosynthesis is also a …
Authors
Mobilio D; Singh SK; Chafe SC
Journal
Molecular Cancer Therapeutics, Vol. 22, No. 12_Supplement, pp. a109–a109
Publisher
American Association for Cancer Research (AACR)
Publication Date
December 1, 2023
DOI
10.1158/1535-7163.targ-23-a109
ISSN
1535-7163